RDW Blood Test: What a High RDW Means, and What It Cannot Settle

The MCV on the same report narrows down what a high RDW means:

The normal-MCV row surprises people most. When the marrow changes what it produces, the cells already in circulation stay for weeks, so a sample can hold older normal-sized cells beside newer ones. Averaged together, the MCV still looks normal while the RDW has already risen. A count with an MCV of 91 and an RDW of 16.4 can belong to someone short of both iron and vitamin B12 or folate: a group of small cells and a group of large ones whose sizes cancel out.

Recovery does something similar with no deficiency at all. After bleeding, a blood donation or a course of iron, the marrow releases many young cells, counted as reticulocytes, which are larger than mature ones and widen the spread. Pregnancy can widen it too. The MCV vs RDW comparison covers these pairings in more depth.

When a high RDW comes with large cells, clinicians usually check B12 and folate together, because treating a folate shortage while B12 is also low can let nerve damage progress.

Small cells have two common causes that look alike on size alone. Iron deficiency develops gradually as the marrow runs short of iron, so it produces an uneven mix and the RDW runs high. Thalassemia trait is inherited and present from birth, so the cells are consistently small and the RDW often stays normal.

Some clinicians add the Mentzer index: the MCV divided by the red blood cell count in millions per microliter. A result above 13 favors iron deficiency and one below 13 favors beta-thalassemia trait, so an MCV of 70 with a count of 4.5 gives 15.6 and leans toward iron. It is only a hint. A 2024 study in children with small red cells found the index identified 74 percent of those with beta-thalassemia trait and correctly cleared 63 percent of those without it, and judged it not a reliable way to tell the two apart.

Other tests settle it. The American Society of Hematology treats a ferritin of 30 ng/mL or lower as iron deficiency in adults, or 50 or lower in higher-risk groups such as people with heavy periods; ferritin usually comes with iron studies. For thalassemia, the NHLBI describes hemoglobin tests that show which types of hemoglobin are present, with genetic testing to confirm the specific form.

Most reports print RDW-CV: the standard deviation of cell sizes divided by the MCV, times 100, which is where the percentage comes from. RDW-SD is a separate measurement, the width of the same size curve read in femtoliters near its base, with no reference to the average. It is not the standard deviation in other units, and there is no formula to convert one into the other.

Because RDW-CV divides by the MCV, it reads higher when cells are small. A spread of about 9 fL gives an RDW-CV of 10 percent at an MCV of 90, but 13 percent at an MCV of 68, with no change in how mixed the cells are. That is one reason small-cell samples trip the RDW flag so readily, and why the two forms have separate reference ranges that cannot be swapped.

MedlinePlus lists chronic liver disease, heart disease, diabetes, kidney disease and some cancers, especially colorectal cancer, among conditions associated with a high RDW. That list worries people, but RDW is not a screening test for any of them. A single raised result in someone without anemia or symptoms is not evidence of one; the link mostly reflects how sensitive red cell production is to long-term illness. A high RDW that no deficiency explains, and that persists on repeat counts in someone with symptoms, is a reason for a broader look.

RDW also has a practical strength: it is built from cell sizes alone, with no hemoglobin reading involved. When fatty plasma throws off the hemoglobin measurement and pushes the MCHC to an impossible value, the RDW is usually unaffected.

Because red cell production changes gradually, RDW is one of the few lines on the complete blood count worth watching across years. An RDW that goes 13.1, 13.9, 14.8 over three yearly counts can show a slow iron or vitamin drift before anyone feels it, and one settling back down suggests a treated deficiency is resolving. Replacing iron or B12 does not tidy the size curve immediately, because the mismatched cells already in circulation have to age out first, so a recheck too soon can look disappointing. More on reading a result as a trend.